GlassScriptPhysician profile
Kent Yinger
NPI 1093815110
$808.76
in general payments reported to CMS, 2019-2025
11 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $17.28 · 2023: $363 · 2024: $120 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $177.03 | 2023-2025 | |
| Arthrex, INC. | $153.84 | 2023 | |
| Medical Device Business Services, INC. | $138.57 | 2019-2023 | Inhance |
| Stryker Corporation | $132.71 | 2023-2025 | 1788, Variax, Blueprint Patient Specific Instrumentation |
| Depuy Synthes Sales INC. | $45.91 | 2019 | |
| Bioventus LLC | $43.76 | 2023 | Durolane |
| Derma Sciences, INC. | $28.89 | 2019 | |
| Spr Therapeutics, INC | $26.30 | 2025 | Sprint Pns System |
| Hydrocision, INC. | $26.06 | 2025 | Tenjet |
| Amgen INC. | $18.41 | 2024 | Prolia, Evenity |
| Zimmer Biomet Holdings, INC. | $17.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Yinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.